Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis • Case report

Bannwarth, 2011, Clinical safety of tocilizumab in rheumatoid arthritis, Expert Opin Drug Saf, 10, 123, 10.1517/14740338.2011.537256 Campbell, 2011, Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials, Rheumatology (Oxford), 50, 552, 10.1093/rheumatology/keq343 Yoshida, 2012, Necrotizing fasciitis in a patient with rheumatoid arthritis treated with tocilizumab, Mod Rheumatol, 22, 317, 10.3109/s10165-011-0505-9 van de Sande, 2012, Necrotizing fasciitis in a rheumatoid arthritis patient treated with tocilizumab, Rheumatology, 51, 577, 10.1093/rheumatology/ker336 Hashimoto, 2015, Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab, Acta Derm Venereol, 95, 370, 10.2340/00015555-1952 Smyth, 2010, Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report, Med Case Rep, 4, 367, 10.1186/1752-1947-4-367 Chan, 2002, Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis, Postgrad Med J, 78, 47, 10.1136/pmj.78.915.47 Baghai, 2001, Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept, Mayo Clin Proc, 76, 653, 10.1016/S0025-6196(11)62418-X Hernández MV1, 2013, Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases, Arthritis Care Res (Hoboken), 65, 2024, 10.1002/acr.22096 Galloway, 2013, Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register, Ann Rheum Dis, 72, 229, 10.1136/annrheumdis-2011-201108 Lang, 2012, Risk of infections in rheumatoid arthritis patients treated with tocilizumab, Rheumatology (Oxford), 51, 852, 10.1093/rheumatology/ker223